RecruitingNCT06704594
Sertraline and hormone-related mood symptoms before menstruation
About this title
Read the official source — NCT06704594Medication studyAges 18–50United StatesMental health
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
- Listed locations
- Baltimore and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 14, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 288
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT06704594
- Official title
Show the full official title
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
Recruitment & locations
RecruitingBaltimore · Charlottesville
A listed location does not confirm current availability.
Questions about this study
What will I need to do?
You will complete questionnaires.
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Does this study involve medication?
Yes. The study involves medication, including sertraline 50 mg daily and Placebo Oral Tablet.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as recruiting.
